European Medicines Agency defends its approach after British claims of Brexit success story
The European Medicines Agency has suggested British regulators prioritised speed over winning public confidence to enable the UK to become the first western country to license a coronavirus vaccine.
After it was announced that the Pfizer/BioNTech vaccine had been authorised for emergency use by the UK’s Medicines and Healthcare products Regulatory Authority (MHRA), the EU agency issued a statement backing its own “robust” approach.
